CH632161A5 - Composizione farmaceutica per il trattamento dell'asma. - Google Patents

Composizione farmaceutica per il trattamento dell'asma. Download PDF

Info

Publication number
CH632161A5
CH632161A5 CH48478A CH48478A CH632161A5 CH 632161 A5 CH632161 A5 CH 632161A5 CH 48478 A CH48478 A CH 48478A CH 48478 A CH48478 A CH 48478A CH 632161 A5 CH632161 A5 CH 632161A5
Authority
CH
Switzerland
Prior art keywords
pharmaceutical composition
composition according
active ingredient
asthma
administration
Prior art date
Application number
CH48478A
Other languages
English (en)
Italian (it)
Inventor
Giorgio Ferrari
Vittorio Vecchietti
Original Assignee
Siphar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar Sa filed Critical Siphar Sa
Priority to CH48478A priority Critical patent/CH632161A5/it
Priority to GB7835598A priority patent/GB2012166A/en
Priority to FR7826151A priority patent/FR2414333A2/fr
Priority to BE190429A priority patent/BE870414R/fr
Priority to JP11246178A priority patent/JPS54100396A/ja
Publication of CH632161A5 publication Critical patent/CH632161A5/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH48478A 1978-01-17 1978-01-17 Composizione farmaceutica per il trattamento dell'asma. CH632161A5 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CH48478A CH632161A5 (it) 1978-01-17 1978-01-17 Composizione farmaceutica per il trattamento dell'asma.
GB7835598A GB2012166A (en) 1978-01-17 1978-09-05 Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.
FR7826151A FR2414333A2 (fr) 1978-01-17 1978-09-12 Composition pharmaceutique contenant comme ingredient actif la d-2-bromo 6-methyl-8b-(morpholinocarbonyoxymethyl)-ergoline, utile notamment pour le traitement de l'asthme
BE190429A BE870414R (fr) 1978-01-17 1978-09-12 Nouveaux carbamates de 2-halogenoergolines et 2-halogenoergolenes, utiles notamment comme vasodilatateurs, et leur procede de preparation
JP11246178A JPS54100396A (en) 1978-01-17 1978-09-14 Medical compositionf for curing asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH48478A CH632161A5 (it) 1978-01-17 1978-01-17 Composizione farmaceutica per il trattamento dell'asma.

Publications (1)

Publication Number Publication Date
CH632161A5 true CH632161A5 (it) 1982-09-30

Family

ID=4188059

Family Applications (1)

Application Number Title Priority Date Filing Date
CH48478A CH632161A5 (it) 1978-01-17 1978-01-17 Composizione farmaceutica per il trattamento dell'asma.

Country Status (5)

Country Link
JP (1) JPS54100396A (fr)
BE (1) BE870414R (fr)
CH (1) CH632161A5 (fr)
FR (1) FR2414333A2 (fr)
GB (1) GB2012166A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8602372D0 (en) * 1986-01-31 1986-03-05 Sandoz Ltd Organic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH619709A5 (en) * 1975-03-14 1980-10-15 Siphar Sa Process for the preparation of carbamates of 2-halogenoergolines and 2-halogenoergolenes

Also Published As

Publication number Publication date
FR2414333A2 (fr) 1979-08-10
JPS54100396A (en) 1979-08-08
GB2012166A (en) 1979-07-25
BE870414R (fr) 1979-01-02

Similar Documents

Publication Publication Date Title
EP3668859B1 (fr) Formes solides d'un inhibiteur de capside du vih
DE69824277T2 (de) Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten
DE69114117T2 (de) Neue Verwendung von Peptidderivat.
DE3827253A1 (de) Ester und amide von cyclischen carbonsaeuren und cyclischen alkoholen und aminen sowie verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
CA2083683C (fr) Formulation stable a base de sel d'analapril; methode de preparation et utilisation
DE10201550A1 (de) Phenoxy-Piperidine
DE60106953T2 (de) Adenosinderivate und deren verwendung
EP4520752A1 (fr) Sel de carebastine et son utilisation
CN105566314B (zh) 一种盐酸替扎尼定化合物
CH632161A5 (it) Composizione farmaceutica per il trattamento dell'asma.
DE602004010837T2 (de) Pharmazeutische zusammensetzung auf basis eines idazoxan-salzes oder eines seiner polymorphen
DE2416491C3 (de) 13.02.74 V.SLVAmerika 442033 Dibenzopyranverbindungen und diese enthaltende Arzneimittel Abbott Laboratories, North Chicago, 111. (V.StA.)
FI82045B (fi) Foerfarande foer framstaellning av den terapeutiskt anvaendbara polymorf i-formen av monoetanolaminosaltet av n-(2-pyridyl)-2-metyl-4-hydroxi-2h-1,2-bensotiazin-3-karboamid-1,1 dioxid.
US4465692A (en) Selective D-2 dopamine receptor agonist
GB2257430A (en) Piperazine derivatives
CA1055934A (fr) Derives de la rifamycine
Singh et al. Fate of embelin in Pippalyadi Yoga, an ayurvedic oral contraceptive: structure of embelin-borax complex and evaluation of anti-fertility activity
US3819705A (en) Quaternary salts of tri-(beta-propyloxyethyl)amine derivatives and process for producing same
DE112020006237T5 (de) Deuterierte Analoga von Selenophenochromenen, deren Synthese und Verfahren zur Verwendung dieser Mittel
JPH07138156A (ja) 免疫抑制剤
PT93009A (pt) Processo para a preparacao de novos acidos aril- ou heteroaril-1-alquil-pirrol--2-carboxilicos uteis no tratamento de situacoes mediadas pela interleucina -1
JPH0791273B2 (ja) ベンズイミダゾール誘導体薬剤組成物
PL120041B1 (en) Process for preparing novel derivatives of cyclodecane
DE69625379T2 (de) Salze des n-[4-oxo-2-(1h-tetrazoyl-5-yl)-4h-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamids
DE69929315T2 (de) Kristalline formen von 1s-ä1alpha(2s*,3r*),9alphaü-6,10-dioxo-n- (2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-ää(1-isochinolyl)carbonylü- aminoüoctahydro-6h-piridazinoä1,2-aüä1,2üdiazepin-1-carboxyamid

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased